Side Effects of Dutasteride
Dutasteride causes sexual dysfunction (impotence, decreased libido, ejaculation disorders), breast enlargement/tenderness, and may increase the risk of high-grade prostate cancer, with some sexual side effects potentially persisting even after stopping the medication. 1
Primary Sexual and Endocrine Side Effects
The FDA-approved labeling clearly identifies the most common adverse reactions 1:
Sexual Dysfunction (Most Common)
- Impotence/erectile dysfunction: 4.7% in first 6 months (vs 1.7% placebo), decreasing to 0.8% by months 19-24
- Decreased libido: 3% in first 6 months (vs 1.4% placebo), decreasing to 0.3% by months 19-24
- Ejaculation disorders: 1.4% in first 6 months (vs 0.5% placebo)
- Critical warning: These sexual adverse reactions may persist after treatment discontinuation, though the role of dutasteride in this persistence remains unknown 1
Breast-Related Effects
- Breast disorders (enlargement and tenderness): 0.5-1.1% over 24 months (vs 0.1-0.3% placebo)
- If breast lumps or nipple discharge develop, immediate evaluation is required 1
Serious Safety Concerns
High-Grade Prostate Cancer Risk
The REDUCE trial demonstrated an increased incidence of Gleason score 8-10 prostate cancer in men taking dutasteride (1% vs 0.5% placebo) 1. This mirrors findings with finasteride and represents a critical consideration when prescribing 5α-reductase inhibitors 2.
Fertility and Reproductive Effects
- Reduced sperm count, semen volume, and sperm motility at 52 weeks 1
- Recent evidence shows persistent impairment with long-term use: cutoff values of 17.8 months for semen volume and 20.3 months for total sperm motility 3
- Effects on total sperm count were not reversible after 24 weeks of follow-up 1
- Men with preexisting fertility issues should avoid dutasteride 4
Pregnancy-Related Warnings
Absolute contraindication: Pregnant women or women who may become pregnant must not handle dutasteride capsules 1. The drug can be absorbed through skin and cause abnormal sex organ development in male fetuses. If contact occurs, wash immediately with soap and water.
Rare but Serious Allergic Reactions
- Facial, tongue, or throat swelling
- Serious skin reactions including skin peeling
- These require immediate medical attention 1
Additional Adverse Effects
Metabolic and Systemic Concerns
Emerging research suggests long-term use may be associated with 5:
- Non-alcoholic fatty liver disease (NAFLD)
- Insulin resistance and type 2 diabetes
- Dry eye disease
- Potential kidney dysfunction
Prostatic Inflammation
Duration of dutasteride administration correlates strongly with increased chronic prostatic inflammation (correlation coefficient = 0.595), despite improving prostatic hyperplasia 6.
Important Clinical Considerations
PSA Suppression
Dutasteride causes a greater and more consistent decrease in DHT than finasteride, leading to PSA suppression 2. This must be accounted for when screening for prostate cancer, though no specific multiplier has been validated for dutasteride.
Discontinuation Rates
- Overall discontinuation rate: approximately 4% (vs 3% placebo)
- Discontinuation due to adverse events: 6-7% in both treatment and placebo groups 2
- Most common reason for withdrawal: impotence (1%) 1
Blood Donation Restriction
Men must not donate blood until 6 months after their last dose to prevent potential exposure to pregnant women through transfusion 1.
Combination Therapy Considerations
When dutasteride is combined with tamsulosin, ejaculation disorders increase significantly to 11% (vs 2% with dutasteride alone or 4% with tamsulosin alone) 1. Dizziness also becomes more prominent in combination therapy.